Latest Breaking News On - Blue earth therapeutics - Page 1 : comparemela.com

Shine Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility

Blue Earth Therapeutics will leverage Shine's non-carrier added lutetium-177 chloride, Ilumira, in a new treatment for prostate cancer undergoing clinical trials

United statesDavid gaudenShine technologiesAmerican cancer societyDrug administrationBlue earth therapeuticsDrug master fileEarth therapeuticsNorth americaBlue earthGreg piefer

Blue Earth Diagnostics Highlights Presentations on POSLUMA (Flotufolastat F 18), Axumin (Fluciclovine F 18) and Investigational 18F-Flotufolastat/18F-rhPSMA-7 at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced upcoming presentations by its collaborators

United kingdomUnited statesMarkt schwabenDavide gaudenSean collinsClare gidleyPriscilla harlanIsabel rauscherIsmaheel lawalNadine mallakElizabeth hawkMike beyerTodd cohenScience universityBracco groupGeorgetown university hospital

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesMike beyerBruce spottiswoodeScintomics gmbDavid gaudenClare gidleyPriscilla harlanSiemens healthineersA siemens healthineers companyTechnical university of munichBracco groupSam brown incNuclear medicineBlue earth diagnostics ltdSolutions inc

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA® (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA® (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSiemens healthineersScintomics gmbDavid gaudenBruce spottiswoodeTechnical university of munichBracco groupBlue earth diagnostics ltdSolutions incClinical applications researchNuclear medicineA siemens healthineers companyDrug administrationClinical data to support algorithms developmentEarth diagnostics announces agreementClinical data

Blue Earth Therapeutics Announces Promising Results from Preclinical Evaluation of Synergistic Drug Combinations with Radiopharmaceutical 177Lu-rhPSMA-10 1 for Treatment of Prostate Cancer

177Lutetium-labeled radiohybrid Prostate-Specific Membrane Antigen (177Lu-rhPSMA-10.1) is in development as a highly optimized, next generation therapeutic radiopharmaceutical

United statesSan diegoDavide gaudenScintomics gmbTechnical university of munichAmerican association for cancer researchBlue earth therapeuticsAmerican associationCancer researchAnnual meetingProstate specific membrane antigen targetedBlue earth therapeuticChief executive officerBlue earthRadiohybrid prostate specific membrane antigenTechnical university